All AbMole products are for research use only, cannot be used for human consumption.
Indatuximab is a chimeric antibody that targets Syndecan-1/CD138. The predicted molecular weight (MW) of Indatuximab is 145.5 kDa. Indatuximab can be used for the research of multiple myeloma and CD138-positive solid tumors.
Immobilized hu-CD138 at 2 μg/mL can bind Indatuximab, the EC50 is 17.8 ng/mL.
| Gene ID | 6382 [NCBI] |
| Form | Solution/Lyophilized powder |
| Storage | Store at -80°C for 2 years. Avoid repeated freeze-thaw cycles. |
| Related Immunology/Inflammation Products |
|---|
| Daratumumab
Daratumumab (Daratumumab) is a first-in-class, specific anti-CD38 monoclonal antibody (IgG1). (for human or immunodeficient mice). |
| Laquinimod
Laquinimod (ABR-215062) is a new orally active immunoregulator effectively inhibits development and relapses of experimental autoimmune encephalomyelitis. |
| Mycophenolic acid
Mycophenolic acid is an immunosuppressant agent used to prevent rejection in organ transplantation. |
| TAPI-1
TAPI-1 is an ADAM17/TACE inhibitor that blocks shedding of cytokine receptors with IC50 value of 8.09 microM. |
| Dipsacoside B
Dipsacoside B is extracted from Lonicara confusa DC. dried buds and flowers. Dipsacoside B showes strong antimicrobial activity. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
